These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 21124766

  • 21. Integrative analysis of gene alterations and immunoexpression profiles of cell cycle checkpoints in oral squamous cell carcinoma.
    Pérez-Sayáns M, Chamorro-Petronacci CM, Lorenzo-Pouso AI, Peñaranda JMS, López-López J, Blanco-Carrión A, García-García A.
    Cancer Biomark; 2020; 27(1):95-103. PubMed ID: 31683463
    [Abstract] [Full Text] [Related]

  • 22. Adenosine A2b receptor promotes progression of human oral cancer.
    Kasama H, Sakamoto Y, Kasamatsu A, Okamoto A, Koyama T, Minakawa Y, Ogawara K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
    BMC Cancer; 2015 Jul 31; 15():563. PubMed ID: 26228921
    [Abstract] [Full Text] [Related]

  • 23. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
    Koyama T, Ogawara K, Kasamatsu A, Okamoto A, Kasama H, Minakawa Y, Shimada K, Yokoe H, Shiiba M, Tanzawa H, Uzawa K.
    Cancer Med; 2015 May 31; 4(5):759-69. PubMed ID: 25644496
    [Abstract] [Full Text] [Related]

  • 24. Overexpression of cell cycle regulator CDCA3 promotes oral cancer progression by enhancing cell proliferation with prevention of G1 phase arrest.
    Uchida F, Uzawa K, Kasamatsu A, Takatori H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Bukawa H.
    BMC Cancer; 2012 Jul 28; 12():321. PubMed ID: 22839099
    [Abstract] [Full Text] [Related]

  • 25. Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway.
    Baba T, Sakamoto Y, Kasamatsu A, Minakawa Y, Yokota S, Higo M, Yokoe H, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    Mol Carcinog; 2015 Aug 28; 54(8):608-17. PubMed ID: 24375483
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Tripeptidyl peptidase II in human oral squamous cell carcinoma.
    Usukura K, Kasamatsu A, Okamoto A, Kouzu Y, Higo M, Koike H, Sakamoto Y, Ogawara K, Shiiba M, Tanzawa H, Uzawa K.
    J Cancer Res Clin Oncol; 2013 Jan 28; 139(1):123-30. PubMed ID: 22986808
    [Abstract] [Full Text] [Related]

  • 28. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
    Nemes JA, Nemes Z, Márton IJ.
    J Oral Pathol Med; 2005 May 28; 34(5):274-9. PubMed ID: 15817070
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L, Wang Y, Xiao M, Lin Y, Yu L.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct 28; 110(4):484-91. PubMed ID: 20868995
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical significance of gelsolin-like actin-capping protein expression in oral carcinogenesis: an immunohistochemical study of premalignant and malignant lesions of the oral cavity.
    Nomura H, Uzawa K, Ishigami T, Kouzu Y, Koike H, Ogawara K, Siiba M, Bukawa H, Yokoe H, Kubosawa H, Tanzawa H.
    BMC Cancer; 2008 Feb 01; 8():39. PubMed ID: 18237446
    [Abstract] [Full Text] [Related]

  • 33. S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrest.
    Sapkota D, Costea DE, Blø M, Bruland O, Lorens JB, Vasstrand EN, Ibrahim SO.
    Oral Oncol; 2012 Mar 01; 48(3):219-25. PubMed ID: 22032898
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
    Yamano Y, Uzawa K, Shinozuka K, Fushimi K, Ishigami T, Nomura H, Ogawara K, Shiiba M, Yokoe H, Tanzawa H.
    Int J Oncol; 2008 May 01; 32(5):1001-9. PubMed ID: 18425326
    [Abstract] [Full Text] [Related]

  • 39. ClC-3 Chloride Channel Proteins Regulate the Cell Cycle by Up-regulating cyclin D1-CDK4/6 through Suppressing p21/p27 Expression in Nasopharyngeal Carcinoma Cells.
    Ye D, Luo H, Lai Z, Zou L, Zhu L, Mao J, Jacob T, Ye W, Wang L, Chen L.
    Sci Rep; 2016 Jul 25; 6():30276. PubMed ID: 27451945
    [Abstract] [Full Text] [Related]

  • 40. Cyclin D1 and cyclin D-dependent kinases enhance oral keratinocyte proliferation but do not block keratinocyte differentiation.
    Woods M, Pant R, Mallya SM.
    Int J Oncol; 2010 Dec 25; 37(6):1471-5. PubMed ID: 21042715
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.